Vir Biotechnology has built a strong foundation based on cutting-edge core scientific capabilities and a world-class team of experts who bring unmatched knowledge and experience to our R&D efforts. This has enabled us to make significant strides in developing treatments for infectious diseases and strategically expand our approach to address critical oncology indications with limited treatment options.
Vir Biotechnology Inc.
Vir Biotechnology leverages the immense potential of the immune system to address critical unmet medical needs and improve patient outcomes.
Building on our strengths to reach further
Activities
Main Activity
Licensing-In (Partial)
Licensing-Out (Partial)
Development (Partial)
Drug discovery
Drug development
Drug commercialization (Partial)
Therapeutic Areas
Infectious diseases
Oncology
Respiratory (Partial)
Drug Stages
Pre-clinical
Clinical Phase I/Phase III
Phase I - Phase III
Registration (Partial)
Market (Partial)